| Literature DB >> 30656159 |
Kwang-Jun Kim1, Hong-Sun Song1, Dong Hyun Yoon2, David H Fukuda3, Soon Hee Kim4, Dong-Ho Park5.
Abstract
This study was designed to investigate the effects of β-alanine (BA) supplementation on peak power, power drop, and lactate response in elite male amateur boxers. Nineteen male Korean national team boxers were divided into groups with either BA (n=9) or placebo (PL, n=10) supplementation. BA consumed 4.9-5.4 g/day of BA with training for 10 weeks and PL took PL in a similar manner. Physical fitness and lactate changes in sparring were measured before and after the 10-week intervention. Significant interactions (P<0.05) were shown for lower body peak power (P=0.049) and upper body power drop (P=0.042). Positive effects for the BA group were shown for lower body peak power (Cohen d=0.72; 95% confidence interval [CI], 0.09-1.35) and the maintenance of upper body power output (d=-0.91; 95% CI, -1.61 to -0.17). These findings suggest that Korean national amateur boxers who consumed BA demonstrated differential responses following a training intervention in specific physical fitness when compared to boxing athletes who consumed a PL.Entities:
Keywords: Amateur boxer; Lactate; Physical fitness; Training; β-Alanine
Year: 2018 PMID: 30656159 PMCID: PMC6323321 DOI: 10.12965/jer.1836462.231
Source DB: PubMed Journal: J Exerc Rehabil ISSN: 2288-176X
Characteristics of participants in the β-alanine (BA) and placebo (PL) groups
| Variable | BA group (n=9) | PL group (n=10) |
|---|---|---|
| Age (yr) | 23.00±1.82 | 22.20±2.21 |
| Height (cm) | 180.41±7.42 | 178.59±6.33 |
| Weight (kg) | 77.25±20.64 | 75.31±19.21 |
| Body fat (%) | 12.30±7.89 | 13.87±6.44 |
| Body mass index (kg/m2) | 23.60±5.51 | 24.03±4.49 |
| Career (yr) | 7.27±0.95 | 7.41±0.73 |
Values are presented as mean±standard deviation.
Outline of the 10-week training program
| Variable | Content |
|---|---|
| Strength & power-circuit training | |
| Goal | Improvement of strength, power & power endurance |
| Intensity & No. of repetitions | Strength: 70%–80% 1RM; 12–15 repetitions (Mon/Thu a.m.) |
| Power-circuit: 60%–70% 1RM; 8–10 repetitions (Tue/Fri a.m.) | |
| Frequency | 2 times/wk |
|
| |
| Elastic tubing training | |
| Goal | Improvement of power & power endurance |
| Intensity | Explosive rhythm (30 sec–3 min) |
| Frequency | 2 times/wk (Tue/Thu p.m.) |
1RM, one-repetition maximum; Mon, Monday; Tue, Tuesday; Thu, Thursday; Fri, Friday.
Physical fitness variables for the β-alanine (BA) and placebo (PL) prior to (pre) and following (post) 10-weeks of β-alanine supplementation
| Physical fitness | Group | Pre | Post | |
|---|---|---|---|---|
| Maximal strength | ||||
| Bench press (kg) | BA | 83.55±22.86 | 87.88±24.29 | a: 0.302 |
| PL | 83.30±23.08 | 82.80±19.33 | b: 0.795 | |
| a×b: 0.197 | ||||
| Squat (kg) | BA | 160.77±38.59 | 167.55±48.84 | a: 0.404 |
| PL | 153.20±36.95 | 157.60±23.28 | b: 0.591 | |
| a×b: 0.858 | ||||
|
| ||||
| Isokinetic strength | ||||
| Knee flexion (right) (%BW) | BA | 153.24±14.53 | 157.24±11.44 | a: 0.411 |
| PL | 148.96±15.57 | 150.57±14.05 | b: 0.385 | |
| a×b: 0.723 | ||||
| Knee extension (right) (%BW) | BA | 278.07±34.88 | 282.33±32.55 | a: 0.536 |
| PL | 276.26±38.16 | 277.71±36.37 | b: 0.841 | |
| a×b: 0.760 | ||||
| Knee flexion (left) (%BW) | BA | 146.79±21.19 | 149.82±20.40 | a: 0.432 |
| PL | 142.04±17.21 | 145.18±20.54 | b: 0.578 | |
| a×b: 0.989 | ||||
| Knee extension (left) (%BW) | BA | 260.99±40.40 | 280.78±32.61 | a: 0.043 |
| PL | 254.01±18.63 | 269.95±33.03 | b: 0.474 | |
| a×b: 0.816 | ||||
| Trunk flexion (%BW) | BA | 368.76±60.94 | 370.79±58.06 | a: 0.850 |
| PL | 351.34±31.05 | 352.50±50.10 | b: 0.425 | |
| a×b: 0.959 | ||||
| Trunk extension (%BW) | BA | 417.07±53.15 | 421.51±82.96 | a: 0.832 |
| PL | 399.22±63.65 | 399.11±58.74 | b: 0.486 | |
| a×b: 0.824 | ||||
|
| ||||
| Muscle power | ||||
| Sargent jump (cm) | BA | 51.77±7.74 | 55.11±8.70 | a: 0.040 |
| PL | 49.30±6.18 | 51.00±3.71 | b: 0.271 | |
| a×b: 0.480 | ||||
| Peak power (lower) (w/kg) | BA | 8.25±1.28 | 8.75±0.91 | a: 0.398 |
| PL | 8.44±0.54 | 8.24±0.30 | b: 0.633 | |
| a×b: 0.049 | ||||
| Peak power (upper) (w/kg) | BA | 13.14±2.08 | 13.75±2.65 | a: 0.260 |
| PL | 13.66±1.69 | 13.90±1.47 | b: 0.697 | |
| a×b: 0.615 | ||||
| Mean power (lower) (w/kg) | BA | 6.70±0.63 | 6.82±0.65 | a: 0.854 |
| PL | 6.83±0.88 | 6.66±0.53 | b: 0.954 | |
| a×b: 0.400 | ||||
| Mean power (upper) (w/kg) | BA | 4.57±0.81 | 4.74±0.40 | a: 0.392 |
| PL | 4.44±0.93 | 4.51±0.67 | b: 0.568 | |
| a×b: 0.736 | ||||
|
| ||||
| Power endurance | ||||
| Sit up (times/min) | BA | 52.33±7.24 | 52.11±7.88 | a: 0.362 |
| PL | 48.10±3.60 | 50.90±6.87 | b: 0.322 | |
| a×b: 0.287 | ||||
| Push up (times/min) | BA | 56.88±14.03 | 59.00±14.88 | a: 0.650 |
| PL | 63.50±8.79 | 63.80±14.34 | b: 0.311 | |
| a×b: 0.733 | ||||
| Repeated jump (times/min) | BA | 92.77±10.29 | 94.33±7.28 | a: 0.991 |
| PL | 93.10±12.09 | 91.60±7.60 | b: 0.747 | |
| a×b: 0.535 | ||||
| Power drop (lower) (%) | BA | 53.21±2.99 | 50.13±8.20 | a: 0.579 |
| PL | 50.05±6.46 | 51.11±5.25 | b: 0.612 | |
| a×b: 0.264 | ||||
| Power drop (upper) (%) | BA | 82.28±6.32 | 79.66±6.17 | a: 0.743 |
| PL | 80.27±6.86 | 83.82±5.79 | b: 0.676 | |
| a×b: 0.042 | ||||
a, time; b, group; a×b, time×group interaction; BW, body weight.
P<0.05.
Power drop=(peak power-minimum power)/peak power×100.
Blood lactate concentrations (in mmol/L; mean±SD) during sparring and recovery for the β-alanine (BA) and placebo (PL) prior to (pre) and following (post) 10 weeks of β-alanine supplementation
| Group | Treatment | Rest | Sparring | Recovery | |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||
| After 1st round | After 2nd round | After 3rd round | 3 min | 5 min | 15 min | ||||
| BA | Pre | 1.86±0.36 | 6.93±1.47 | 9.17±1.37 | 9.99±1.48 | 8.99±1.82 | 8.35±1.70 | 5.23±1.38 | a: 0.329 |
| Post | 1.88±0.33 | 7.80±2.69 | 9.80±3.33 | 11.63±4.02 | 9.43±2.90 | 8.91±2.78 | 6.55±3.14 | b: 0.004 | |
| a×b: 0.171 | |||||||||
|
| |||||||||
| PL | Pre | 2.06±0.41 | 6.99±1.27 | 8.74±2.12 | 9.66±2.40 | 8.31±2.48 | 7.41±2.18 | 5.20±1.73 | a: 0.137 |
| Post | 2.15±0.46 | 8.02±1.92 | 10.00±2.62 | 10.94±2.88 | 9.76±3.27 | 9.21±3.22 | 5.97±2.53 | b: 0.001 | |
| a×b: 0.708 | |||||||||
a, treatment (pre vs. post); b, measuring point; a×b, treatment×measuring point interaction.
All differences are significant at P<0.05.
Different from rest (baseline).
Different from after 1st round.
Different from after 2nd round.
Different from after 3rd round.
Different from 3-min recovery.
Different from 5-min recovery.
Different from 15-min recovery.
Fig. 1The change of lactate concentrations (in mmol/L) during sparring and recovery for the β-alanine (BA) and placebo (PL) prior to (pre) and following (post) 10 weeks of BA supplementation. Both groups showed the high level of lactate after the 3rd round in sparring, particularly BA showed the highest lactate level since the BA supplementation.